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Polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhythmic proper-
ties, which are attributed to their capability to modulate ion channels. This PUFAs ability
has been reported to be due to their effects on the gating properties of ion channels. In
the present review, we will focus on the role of PUFAs on the gating of two Kv channels,
Kv1.5 and Kv11.1. Kv1.5 channels are blocked by n−3 PUFAs of marine [docosahexaenoic
acid (DHA) and eicosapentaenoic acid] and plant origin (alpha-linolenic acid, ALA) at physi-
ological concentrations.The blockade of Kv1.5 channels by PUFAs steeply increased in the
range of membrane potentials coinciding with those of Kv1.5 channel activation, suggest-
ing that PUFAs-channel binding may derive a significant fraction of its voltage sensitivity
through the coupling to channel gating. A similar shift in the activation voltage was noted
for the effects of n–6 arachidonic acid (AA) and DHA on Kv1.1, Kv1.2, and Kv11.1 channels.
PUFAs-Kv1.5 channel interaction is time-dependent, producing a fast decay of the current
upon depolarization. Thus, Kv1.5 channel opening is a prerequisite for the PUFA-channel
interaction. Similar to the Kv1.5 channels, the blockade of Kv11.1 channels by AA and DHA
steeply increased in the range of membrane potentials that coincided with the range of
Kv11.1 channel activation, suggesting that the PUFAs-Kv channel interactions are also cou-
pled to channel gating. Furthermore, AA regulates the inactivation process in other Kv
channels, introducing a fast voltage-dependent inactivation in non-inactivating Kv channels.
These results have been explained within the framework that AA closes voltage-dependent
potassium channels by inducing conformational changes in the selectivity filter, suggesting
that Kv channel gating is lipid dependent.
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INTRODUCTION
The polyunsaturated fatty acids (PUFAs) present in nature belong
to two main classes: the n−6 class and n−3 class. Both n−3 and
n−6 PUFAs are essential nutrients that must be acquired from diet
and are required for normal development and cellular function. In
addition, mammals cannot convert n−6 into n−3 PUFAs. Certain
vegetables can be a source for n−3 PUFAs, such as α-linolenic acid
(ALA; 18:3 n−3), whereas other n−3 PUFAs, including eicosapen-
taenoic acid (EPA; 20:5 n−3) and docosahexaenoic acid (DHA;
22:6 n−3), can be obtained from marine sources (Holman, 1998).
ALA is found in some vegetable oils (i.e., flaxseed, canola, and
soybean) and walnuts, whereas marine n−3 PUFAs are found in
fish and seafood. ALA is the precursor of EPA and DHA, but
the conversion is limited and inefficient in organisms (Brenna,
2002). After ingestion, n−3 PUFAs are widely distributed to the
cells and have effects on the membrane composition and func-
tion, eicosanoid synthesis, signaling, and the regulation of gene
expression (Jump, 2002). A high dietary intake of n−3 PUFAs
has also been linked to favorable physiological alterations, includ-
ing reductions in the triglyceride levels, antithrombotic effects,
enhanced immune function, and antiarrhythmic actions, which
together may contribute to a lower risk of cardiovascular disease
(Calder, 2004).
The dramatic increase in the n−6/n−3 ratio in the diet of
the Western population after the industrial revolution has con-
tributed to the rise in cardiovascular disease (Sinclair, 1953, 1956;
De Caterina et al., 2003; Leaf et al., 2003). Moreover, there is a
growing body of evidence that dietary n−3 PUFAs have an impor-
tant role in the prevention of coronary heart disease by decreasing
the risk of sudden cardiac death and, in particular, in preventing
fatal ventricular arrhythmias (Burr et al., 1989; de Lorgeril et al.,
1994; Singh et al., 1997; GISSI-Prevenzione Investigators, 1999;
Albert et al., 2002; Leaf et al., 2003; Tanaka et al., 2008; Tavazzi
et al., 2008). Finally, n−3 and n−6 PUFAs are metabolized to
lipoxins, resolvins, and maresins (Serhan et al., 2008; Bannenberg
and Serhan, 2010). These EPA- and DHA-derived lipid media-
tors (collectively termed Specific Pro-resolving Mediators; SPMs)
are active, as anti-inflammatory agents, at very low concentra-
tions (picomolar to nanomolar range), and are degraded locally
by specific inactivating enzymes, characteristic for the bioactivity
of autacoids. These SPMs can also slow the progression of diabetic
onset, cardiovascular disease, and aging-associated pathologies
through the regulation of innate and adaptive immune responses.
The antiarrhythmic properties of n−3 PUFAs have been attrib-
uted to their ability to modulate the ion channels involved in the
genesis and/or maintenance of cardiac action potentials. PUFAs
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inhibit the INa, IKur, ITO, IKr, and ICa voltage-gated ion chan-
nels and increase IKs (Honoré et al., 1994; Xiao et al., 1995, 1997;
Doolan et al., 2002; Jude et al., 2003; Guizy et al., 2005, 2008; Verk-
erk et al., 2006; Dujardin et al., 2008), all of which are critical for
biological signaling and regulating ion flux on a millisecond time
scale.
In addition to their effects on the magnitude of the ionic
currents, it has been demonstrated that membrane lipids can con-
vert the Kv A-type channels into delayed rectifiers and vice versa.
Within this framework, phosphoinositides (PIPs) remove the N-
type inactivation, whereas AA converts the Kv delayed rectifiers
into A-type rectifier channels (Oliver et al., 2004). Moreover, PIP2
modulates ion channel gating and the interaction between the
Kv channels and β subunits (Loussouarn et al., 2003; Decher
et al., 2008; Rodriguez et al., 2010; David et al., 2012). In the
present review, we will focus on the effects of PUFAs on the gat-
ing of Kv1.5 and Kv11.1, the cloned counterparts of IKur and IKr,
respectively.
EFFECTS OF n−3 PUFAs ON THE GATING OF Kv1.5 CHANNELS
Kv1.5 channels consist of four subunits, each containing six trans-
membrane segments (S1–S6). The voltage sensor of the channel
is formed by the S1–S4 segments, and the segments S5 and S6,
together with the P-loop form the ion conduction pathway. In
the human heart, these subunits are expressed mainly in the atria
(Roberds and Tamkun, 1991; Tamkun et al., 1991; Fedida et al.,
1993). To sense changes in the membrane voltage, each ion channel
is equipped with four voltage-sensor domains (S1–S4) connected
to a central ion-conducting pore domain. It has been described
that the bilayer-forming lipids interact with the S3 and S4 helices
more strongly than with the S1 and S2 segments. Indeed, there are
several reports indicating an important role of the lipid bilayer in
the channel voltage-sensor (Butterwick and MacKinnon, 2010).
Regarding the pathophysiological roles of these channels, IKur
and ITO comprise the main human atrial repolarizing current.
Moreover, IKur has not been recorded in the human ventricle.
During chronic atrial fibrillation, there is an electrical remodeling
that comprises shortening of the action potential duration and a
lack of adaptation of the action potential duration to an acceler-
ated heartbeat (Dobrev and Ravens, 2003; Wettwer et al., 2004).
Because the Kv1.5 channels are mostly expressed in the atria, they
have been proposed as pharmacological targets for antiarrhythmic
drugs that are effective on supraventricular arrhythmias, such as
atrial fibrillation (Varro et al., 2004; Wettwer, 2007; Dobrev et al.,
2012). In fact, it has been proposed that the blockade of ITO and/or
IKur prolongs the atrial action potential at the plateau but not at
the terminal phase of repolarization, leading to rotor termination
(Pandit et al., 2005; Decher et al., 2006; Dobrev and Nattel, 2010).
The first study dealing with the effects of PUFAs on Kv1.5 chan-
nels was performed by Honoré et al. (1994) who analyzed two
different PUFAs, AA and DHA. These authors reported the AA-
and DHA-induced time-dependent blockade of these channels,
the existence of an external binding site for n−3 PUFAs and also a
change in the gating of Kv1.5 channels that appeared as a negative
shift in the activation curve.
The effects of ALA were qualitatively similar to those previ-
ously reported for DHA and AA (Honoré et al., 1994; Guizy et al.,
2008). This study also showed that ALA both decreases the mag-
nitude of the Kv1.5 current in a time-dependent manner and also
modifies the gating of the channel (Figure 1). In fact, ALA shifts
the activation curve toward negative membrane potentials, and an
acceleration of the activation kinetics was observed in the range
of the activation of the channels, a result that was likely due to
the negative voltage shift (Guizy et al., 2008). A similar shift in
the activation voltage was reported for the effects of AA and DHA
on the Kv1.1 (Gubitosi-Klug and Gross, 1996), Kv1.2, and Kv11.1
channels (Poling et al., 1995; Guizy et al., 2005). Similar to what
was previously described for AA and DHA, the blocking effects
of ALA on the Kv1.5 channels only appeared when the PUFA was
added from the external side of the membrane. In contrast, when
it was applied from the inner side of the cell membrane, the mag-
nitude of the current was not modified, but a hyperpolarizing
shift of the activation curve and a slower deactivation time course
of the current were observed (Figure 1). This finding indicated
that the blocking effects produced by ALA on the Kv1.5 chan-
nels were due to the interaction with an external domain of the
channel or, alternatively, an external domain of another mole-
cule interacting with the ion channel. However, ALA modified
the gating of the channel when it was applied from both sides
of the membrane. Block of the Kv1.5 channels induced by ALA
increased in the range of the membrane potentials that coincided
with those of Kv1.5 channel activation, suggesting that the ALA-
Kv1.5 interaction is voltage-dependent and likely coupled to the
channel gating.
The flanking S5 and S6 segments are considered to contribute
to the presumably wider intracellular mouth of the ion channel
(Aiyar et al., 1994; Lopez et al., 1994) and contain binding sites
for quaternary ammonium open-channel blockers and similarly
acting drugs, such as quinidine or bupivacaine (Choi et al., 1993;
Valenzuela et al., 1995, 1996; Yeola et al., 1996; Arias et al., 2007),
and the Kvβ1.3 regulatory subunit (Decher et al., 2008; David
et al., 2012). Block of Kv1.5 channels by n−3 and n−6 PUFAs
resembles the effects of open-channel blockers and Kvβ1.3 regu-
latory subunits (Snyders et al., 1992; Valenzuela et al., 1995; Yeola
et al., 1996; Franqueza et al., 1997; Gonzalez et al., 2002b; Decher
et al., 2005, 2008; Arias et al., 2007; David et al., 2012). How-
ever, although these open-channel blockers interact with the inner
part of the ion pore (Yeola et al., 1996; Franqueza et al., 1997;
Decher et al., 2004), the PUFAs blockade appeared to be the con-
sequence of their interaction with an external binding site in the
channel. This issue concerning to the action mechanisms by which
PUFAs modify ion channel activity has been a matter of debate. In
fact, there are several pieces of evidence suggesting direct effects
on ion channels (Xiao et al., 2000, 2001), whereas others reports
claim that the effects of PUFAs represent the consequence of their
effects on the physical properties of the lipid bilayer (Girshman
et al., 1997; Bruno et al., 2007; Lundbaek, 2008). In fact, the n−3
and n−6 PUFAs are amphiphilic substances that may modulate
the ion channel function by one of the following mechanisms:
(a) changing the biophysical characteristics of the lipid bilayer;
(b) modifying the hydrophobic interactions between the channel
protein and the lipid bilayer, or (c) interacting specifically with an
amino acid involved in the gating or the permeation of the chan-
nel (Oliver et al., 2004; Boland and Drzewiecki, 2008; Lundbaek,
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FIGURE 1 | (A) Original traces of Kv1.5 channels obtained after applying
the pulse protocol shown in the upper part of the figure in the absence
(Control) and in the presence of 10 and 50µM α-linolenic acid (ALA). (B)
Current-voltage (IV) relationship of Kv1.5 in the absence and in the
presence of 2.5µM ALA. The plot also shows the mean relative current
(IALA/IControl) at each membrane potential. (C) Kv1.5 activation curves
obtained in the absence and in the presence of 2.5µM ALA. The dotted
line shows the activation curve obtained in the presence of ALA
normalized to the matching control values. The data were obtained from
Guizy et al. (2008).
2008; Meves, 2008). Recently, Decher et al. (2010) performed a
study to elucidate the mechanism by which PUFAs modify the
Kv1.x gating and the effects of AA and DHA on “edited” Kv1.x
channels. Kv1.1 belongs to the increasing number of proteins
having an amino acid sequence that is altered by RNA editing
(Hoopengardner et al., 2003). In the “edited” Kv1.1 channels, an
isoleucine facing the inner cavity of the pore is replaced by valine
(I400V). This study shows that the effects of AA or other PUFAs
(such as DHA) were strongly reduced in the “edited” Kv1.1 chan-
nels and also that, in heteromeric channels, the presence of only
one “edited” Kv1.1 subunit was sufficient to decrease the affin-
ity of PUFAs (Decher et al., 2010). This study concludes that the
endogenous lipids AA and DHA produce an open-channel block
of Kv channels, mimicking an increase in the rate of inactiva-
tion. These lipid effects are direct and can be antagonized by RNA
editing of the Kv1.1 channels. However, the existence of “edited”
Kv1.5 channels has not been demonstrated in the heart, brain,
or other tissues. It is known that the isoleucine at position 400
is highly conserved in the Kv1.x channels and is located at the
middle of the S6 helix, forming part of the wall of the central
cavity of the ion channel (Long et al., 2005, 2007). In Kv1.5, the
equivalent I400V position corresponds to I508, and the blocking
effects of AA were also decreased in Kv1.5 I508A mutant chan-
nels. When the Kv1.1 channels were co-expressed with Kvβ1.1, the
fractional block of the steady-state current by AA was strongly
reduced (Decher et al., 2010). These data are consistent with the
idea that Kvβ1.1 and AA compete for the same or overlapping
binding sites located in the inner pore cavity, similar to the mode
of action of quinidine and bupivacaine on Kvβ1.3 (Arias et al.,
2007). Thus, the molecular mechanism of inactivation by AA
might be analogous to the N-type inactivation by the Kvβ1 sub-
units (Decher et al., 2010). These results strongly suggest that, in
contrast to the external binding site proposed by other authors
(Honoré et al., 1994; Guizy et al., 2008), PUFAs seem to bind
to an internal binding site that overlaps with the Kvβ1.3 and
bupivacaine-binding site (Arias et al., 2007; Decher et al., 2008,
2010).
Why do PUFAs induce Kv1.5 block from the external side of
the cell membrane? A possible explanation might be that when
externally applied, PUFAs rapidly cross the lipid bilayer and bind
to their internal receptor in the ion channel (Decher et al., 2010).
Moreover, is it possible that no blocking effects are observed when
PUFAs are applied from the internal side of the membrane. We may
explain this unexpected behavior on the basis that, under these
experimental conditions, PUFAs diffuse through the cell mem-
brane into the bath faster than from the pipette to the membrane,
as has been reported for other agents (DeCoursey, 1995; Brock
et al., 2001; Macias et al., 2010).
EFFECTS OF PUFAs ON THE GATING OF Kv11.1 CHANNELS
Kv11.1 channels are encoded by the human ether-à-go-go-related
gene (KCNH2), and the ionic current generated after their activa-
tion is responsible for the rapid delayed rectifier potassium current
(IKr) in the heart and several other cell types. These channels are
homotetramers of a protein formed by six membrane-spanning
domains with intracellular N- and C-termini. IKr is characterized
by a rapid activation at−30 mV and a strong inward rectification
at positive potentials, which is due to the rapid voltage-dependent
C-type inactivation. Inward rectification results from the fact that
channel inactivation develops faster than channel activation at
www.frontiersin.org September 2012 | Volume 3 | Article 163 | 3
Moreno et al. PUFAs and gating of Kv channels
positive potentials and limits the amount of time that channels
exist in the open state (Smith et al., 1996; Spector et al., 1996).
The KCNH2 gene has been identified as the locus of mutations
associated with type 2 long QT syndrome (LQTS2; Splawski et al.,
2000; Roden et al., 2002; Kass and Moss, 2003). LQTS is a complex
disease characterized by a marked QT interval prolongation and
polymorphic ventricular tachycardia called torsades de pointes
(TdP),causing syncope, seizures,and sudden death (Splawski et al.,
2000; Roden et al., 2002; Kass and Moss, 2003; Shimizu, 2005).
More than 290 mutations in the KCNH2 gene have been described,
including frameshifts, insertions, deletions, and missense and non-
sense mutations (Splawski et al., 2000; Roden et al., 2002; Kass and
Moss, 2003; Shimizu, 2005). Mutant Kv11.1 channels producing
LQTS2 generate reduced outward potassium currents that can be
due to (a) the generation of non-functional channels, (b) altered
channel gating, and/or (c) abnormal protein membrane trafficking
(Thomas et al., 2003; Shimizu, 2005).
There is only one study in which the effects of acute PUFAs were
studied in Kv11.1 channels (Guizy et al., 2005), reporting that the
effects of AA and DHA block the Kv11.1 channels in a manner
consistent with an open-channel block mechanism. The blockade
induced by both of these PUFAs steeply increased in the range
of the membrane potentials coinciding with the range of Kv11.1
channel activation, suggesting (similar to that reported for the
Kv1.5 channels) that their binding may derive a significant fraction
of its voltage sensitivity by coupling to the channel gating. Unfor-
tunately, at strong depolarizing voltages, the open and inactivated
conformations of the Kv11.1 channels are in rapid equilibrium,
making it difficult to unequivocally identify the state(s) with which
these two PUFAs interact.
Although AA induced a similar inhibition of the Kv11.1 current
when measured at the end of depolarizing pulses and at the
maximum tail currents, DHA inhibited this current to a higher
extent when measured at the maximum tail current, suggesting an
open-channel interaction mechanism (Figure 2). During depo-
larization, the Kv11.1 channels inactivate faster than they activate,
and, thus, the amplitude of the current is reduced. Upon repo-
larization, the closed channels recover from inactivation with a
very fast kinetics, resulting in tail currents with higher amplitudes
than the maximum activated current (Smith et al., 1996; Spector
et al., 1996). Experiments in which the transition from the closed
to the inactivated state was removed demonstrated that both AA
and DHA bind to the open state of the Kv11.1 channels in a time-
and use-dependent manner, as previously described for cocaine
and bupivacaine-type local anesthetics (Zhang et al., 2001; Gon-
zalez et al., 2002a). In agreement with these results, the blockade
of Kv11.1 channels induced by AA and DHA measured after the
recovery from fast inactivation was similar (for AA) or higher (for
DHA) than that measured after a long depolarizing pulse in which
most of the Kv11.1 channels were in the inactivated state (Snyders
and Chaudhary, 1996; Spector et al., 1996; Guizy et al., 2005).
The time-dependent interaction with the ion channel was also
evident in the deactivation process of the Kv11.1 channels that was
accelerated in the presence of both AA and DHA. However,AA and
DHA did not modify the onset kinetics of the inactivation process
or the recovery process (Guizy et al., 2005). The faster deactivation
induced by both of the PUFAs, together with their lack of effect
on the recovery kinetics, are consistent with an open-channel
block mechanism, as has been proposed for propafenone (Arias
et al., 2003). Therefore, the time-, use-, and voltage-dependent
interaction with Kv11.1 channels suggest that both AA and DHA
preferentially bind to the open state of these channels and that
DHA exhibits a higher affinity for this state of the channel (Guizy
et al., 2005).
It was also reported that AA and DHA produced a positive
shift of the inactivation curve, which was interpreted to be the
consequence of PUFAs binding to a closed state of the chan-
nel. This interaction is likely to influence the apparent steady-
state inactivation and maybe the activation process (Guizy et al.,
2005). All of these results suggest that AA and DHA prefer-
entially block the open state of Kv11.1 channels but also that
they interact with a closed state, thus producing changes in the
channel gating (Figure 2). However, the similar degree of AA-
induced inhibition of the current at the end of long depolarizing
pulses (when most channels are inactivated), at the maximum
tail current or at the maximum peak current after the recovery
of C-type inactivation cannot permit us to rule out an interac-
tion between AA and the inactivated state of the Kv11.1 channels.
Similarly, AA has also been reported to inhibit Kv11.1, Kv11.2,
and Kv11.3 currents recorded from clonal somatomammotrophic
GH3/B6 cells (Schledermann et al., 2001). These results show a
decrease of the current and a marked acceleration of the deac-
tivation. All of these results that involve a shift of the activa-
tion and inactivation curves, together with a modification of
the deactivation kinetics, may suggest changes in the channel
gating.
As stated above, it has been described that AA regulates the
inactivation process in other potassium channels, introducing
a fast voltage-dependent inactivation into non-inactivating Kv
channels (Oliver et al., 2004). These results are in agreement with
those reported by Guizy et al. (2005). Oliver et al. (2004) explain
these results by proposing that AA inserts into the cell membrane
from either side, interacts with the channel protein and allosteri-
cally induces a rapid closure of the open Kv channel pore through
conformational modifications in the selectivity filter.
EFFECTS OF PUFAs ON Kv4 AND Kv7.1+KCNE1 CHANNELS
As stated above, PUFAs are also able to modulate other cardiac
ion channels present in the heart. Focusing on the outward K+
currents, it has been reported that DHA and AA block ITO,
whereas DHA increases IKs (Singleton et al., 1999; Doolan et al.,
2002; Boland et al., 2009; Xu et al., 2010). These studies show
that both AA and DHA decrease the magnitude of Kv4.3 and
also that AA shifts the activation curve, but not the inactiva-
tion curve, in the presence of KChiP1b but not in the absence
of this accessory subunit. However, DHA shifts the activation
curve both in the absence and in the presence of KChiP1b (Boland
et al., 2009). In contrast, it has been reported that DHA increases
IKs when Kv7.1+KCNE1 was transfected into Xenopus oocytes
(Doolan et al., 2002). Taking all of the effects of DHA on all of
the outward potassium currents together, we can expect small
changes in the duration of the cardiac action potential, as the
blocking effects on IKr, IKur, ITO can be counteracted by the effects
on IKs.
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FIGURE 2 | (A) Original traces of Kv11.1 channels obtained after applying the
pulse protocol shown in the upper part of the figure in the absence (Control)
and in the presence of arachidonic acid (AA) and docohexaenoic acid (DHA) at
10µM. This panel also shows the activation curves of the Kv11.1 channels in
the absence and in the presence of AA and DHA. (B) Apparent voltage
dependence of channel availability. The pulse protocol used to obtain each
data point is shown at the top. Original traces obtained after applying such a
pulse protocol in the absence and in the presence of 10µM AA and DHA.
Corrected data for the deactivation together with the Boltzmann fit. The data
were obtained from Guizy et al. (2005).
CONCLUDING REMARKS
PUFAs have diverse effects on cardiac ion currents. All of the
reports in which PUFA effects have been studied on Kv channels
demonstrate that these molecules modify the channel gating, indi-
cating that the gating of Kv channels can be modified by lipids. This
is not a surprising result, as it has been previously described that
the S3 and S4 helices of the voltage-sensor domain of KvAP chan-
nels exhibit specific interactions with phospholipids. Conversely,
the S1 and S2 helices might present a generic hydrophobic surface
that is more equally satisfied by detergents and long-chain lipids
(Bond and Sansom, 2007; Butterwick and MacKinnon, 2010). It
has also been described that a diet rich in PUFAs is able to modify
the lipid bilayer composition. The effects of PUFAs can be different
and even opposite when they are acutely or chronically applied. In
fact, n−3 PUFAs decrease Kv1.5 channels under both experimen-
tal conditions (Guizy et al., 2008). However, PUFAs decreased the
magnitude of the Kv11.1 current after an acute exposure, whereas
they did not modify this potassium current recorded in myocytes
obtained from animal fed with a diet rich in n−3 PUFAs (Verkerk
et al., 2006; Den Ruijter et al., 2012). These apparent discrepant
results may be explained by two different effects of PUFAs on ion
channels: a direct effect on the ion channel and another produced
after changing the membrane biophysical properties. Both mech-
anisms can modify the gating of the ion channel; however, the
effects on the ion current magnitude will likely derive from direct
PUFA-channel interactions. Further lipidomic and electrophysio-
logical studies using mutant Kv11.1 channels are necessary for a
better understanding of the effects of PUFAs on the gating of Kv
channels.
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